Basic Information | Post buying leads | Suppliers |
Name |
1-Piperidinebutanamide,α-phenyl-α-[2-(1-piperidinyl)ethyl]- |
EINECS | N/A |
CAS No. | 2977-24-4 | Density | 1.06 g/cm3 |
PSA | 50.56000 | LogP | 4.18720 |
Solubility | N/A | Melting Point |
116.5-117.5 °C |
Formula | C22H35N3O | Boiling Point | 549.5 °C at 760 mmHg |
Molecular Weight | 357.539 | Flash Point | 286.1 °C |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
1-Piperidinebutyramide,a-phenyl-a-(2-piperidinoethyl)- (7CI,8CI); |
The 1-Piperidinebutanamide,α-phenyl-α-[2-(1-piperidinyl)ethyl]-, with the CAS registry number 2977-24-4, is also known as alpha,alpha-Bis(2-piperidinoethyl)phenylacetamide. This chemical's molecular formula is C22H35N3O and molecular weight is 357.5328. Its IUPAC name is called 2-phenyl-4-piperidin-1-yl-2-(2-piperidin-1-ylethyl)butanamide. This chemical's classification code is Drug / Therapeutic Agent.
Physical properties of 1-Piperidinebutanamide,α-phenyl-α-[2-(1-piperidinyl)ethyl]-: (1)ACD/LogP: 3.19; (2)ACD/LogD (pH 5.5): -0.91; (3)ACD/LogD (pH 7.4): -0.35; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 1; (7)ACD/KOC (pH 7.4): 1; (8)#H bond acceptors: 4; (9)#H bond donors: 2; (10)#Freely Rotating Bonds: 8; (11)Index of Refraction: 1.546; (12)Molar Refractivity: 106.74 cm3; (13)Molar Volume: 337 cm3; (14)Surface Tension: 44.3 dyne/cm; (15)Density: 1.06 g/cm3; (16)Flash Point: 286.1 °C; (17)Enthalpy of Vaporization: 82.93 kJ/mol; (18)Boiling Point: 549.5 °C at 760 mmHg; (19)Vapour Pressure: 4.01E-12 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)Canonical SMILES: C1CCN(CC1)CCC(CCN2CCCCC2)(C3=CC=CC=C3)C(=O)N
(2)InChI: InChI=1S/C22H35N3O/c23-21(26)22(20-10-4-1-5-11-20,12-18-24-14-6-2-7-15-24)13-19-25-16-8-3-9-17-25/h1,4-5,10-11H,2-3,6-9,12-19H2,(H2,23,26)
(3)InChIKey: TXSYVXMEIWQHCF-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LDLo | intraperitoneal | 120mg/kg (120mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Journal of Medicinal Chemistry. Vol. 8, Pg. 594, 1965. |